In the Press
Selected coverage & mentions.
A selection of articles, interviews and features on my work in clinical oncology, across Dutch and international media.
-
‘Ik kwam al vroeg in mijn carrière op allerlei podia te staan’
A career-spanning interview looking back on more than three decades in medical oncology and the milestones along the way.
-
Ronald de Wit drukte zijn stempel op de behandeling van drie soorten urologische kanker
A retrospective on a 34-year career and its lasting impact on the treatment of testicular, prostate and bladder cancer.
-
Koninklijke onderscheiding voor prof. dr. Ronald de Wit
Appointed Knight in the Order of the Netherlands Lion in recognition of a lifetime of contributions to cancer care.
-
Maak second opinion bespreekbaar bij prostaatkanker
A call for men with prostate cancer to discuss a second opinion, given how rapidly treatment options have evolved.
-
Oncoloog Ronald de Wit in Academia Europaea
Elected to the Academia Europaea in recognition of groundbreaking contributions to cancer research and treatment.
-
Ronald de Wit benoemd tot lid Academia Europaea
News coverage of the appointment to the Academia Europaea, one of the highest honours in European science.
-
Ronald de Wit on Cabazitaxel, Abiraterone, and Enzalutamide in Prostate Cancer
Discussing the CARD trial and the role of cabazitaxel in metastatic castration-resistant prostate cancer at ESMO 2019.
-
Dr. de Wit Discusses Findings With Pembrolizumab in NMIBC
On the KEYNOTE-057 findings and the promise of immunotherapy in high-risk non-muscle-invasive bladder cancer.
-
Expert Point of View: Ronald de Wit, MD, PhD
Calling the addition of docetaxel to androgen-deprivation therapy “the latest paradigm shift” in prostate cancer.
Looking for expert commentary?
Available for interviews, advisory and committee work in clinical oncology. Get in touch to discuss.
Get in contact →